» Authors » Porntip Intapiboon

Porntip Intapiboon

Explore the profile of Porntip Intapiboon including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 12
Citations 54
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ongarj J, Intapiboon P, Surasombatpattana S, Satti I, Harris S, Morrison H, et al.
Tuberculosis (Edinb) . 2024 Jun; 148:102533. PMID: 38878478
Tuberculosis (TB) is an infectious disease with the burden concentrated in low- and middle-income countries. Systemic lupus erythematosus (SLE) is an autoimmune disease associated with widespread inflammation that is prevalent...
2.
Sophonmanee R, Preampruchcha P, Ongarj J, Seeyankem B, Intapiboon P, Surasombatpattana S, et al.
Vaccines (Basel) . 2024 Feb; 12(2). PMID: 38400093
The administration of viral vector and mRNA vaccine booster effectively induces humoral and cellular immune responses. Effector T cell responses after fractional intradermal (ID) vaccination are comparable to those after...
3.
Intapiboon P, Pinpathomrat N, Juthong S, Uea-Areewongsa P, Ongarj J, Siripaitoon B
Vaccines (Basel) . 2023 Mar; 11(3). PMID: 36992120
Immunogenicity data on the mRNA SARS-CoV-2 vaccine booster after completing a primary series vaccination, other than the mRNA vaccine, in patients with autoimmune rheumatic diseases (ARDs) is scarce. In this...
4.
Uea-Areewongsa P, Pinpathomrat N, Ongarj J, Sophonmanee R, Seepathomnarong P, Seeyankem B, et al.
Asian Pac J Allergy Immunol . 2023 Jan; PMID: 36592166
Background: Alongside vaccine hesitancy, impaired and waning immunity in autoimmune rheumatic diseases (ARDs) are barriers to immunization. The timeframe of immunity waning in ARD remains unclear. Objective: We aimed to...
5.
Intapiboon P, Uae-Areewongsa P, Ongarj J, Sophonmanee R, Seepathomnarong P, Seeyankem B, et al.
NPJ Vaccines . 2022 Nov; 7(1):149. PMID: 36379939
Reports on vaccine immunogenicity in patients with systemic autoimmune rheumatic diseases (SARDs) have been inconclusive. Here, we report the immunogenicity of heterologous prime-boost with an inactivated vaccine followed by an...
6.
Sophonmanee R, Ongarj J, Seeyankem B, Seepathomnarong P, Intapiboon P, Surasombatpattana S, et al.
Vaccines (Basel) . 2022 Sep; 10(9). PMID: 36146571
A practical booster vaccine is urgently needed to control the coronavirus disease (COVID-19) pandemic. We have previously reported the safety and immunogenicity of a fractional intradermal booster, using the BNT162b2...
7.
Pinpathomrat N, Intapiboon P, Seepathomnarong P, Ongarj J, Sophonmanee R, Hengprakop J, et al.
NPJ Vaccines . 2022 Sep; 7(1):107. PMID: 36068243
No abstract available.
8.
Pinpathomrat N, Intapiboon P, Seepathomnarong P, Ongarj J, Sophonmanee R, Hengprakop J, et al.
NPJ Vaccines . 2022 May; 7(1):52. PMID: 35562372
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global pandemic. Two doses of an inactivated SARS-CoV-2 vaccine (CoronaVac) have been shown to be insufficient to protect against variants...
9.
Intapiboon P, Seepathomnarong P, Ongarj J, Surasombatpattana S, Uppanisakorn S, Mahasirimongkol S, et al.
Vaccines (Basel) . 2021 Dec; 9(12). PMID: 34960122
Effective vaccine coverage is urgently needed to tackle the COVID-19 pandemic. Inactivated vaccines have been introduced in many countries for emergency usage, but have only provided limited protection. Heterologous vaccination...
10.
Intapiboon P, Siripaitoon B
Respir Med Case Rep . 2020 Dec; 31:101299. PMID: 33294359
Introduction/objectives: The anti-melanoma differentiation-associated gene 5 (Anti-MDA5) antibody is associated with rapidly progressive interstitial lung disease (RP-ILD) and clinically amyopathic dermatomyositis (CADM). The predictors of treatment response would help in...